001060 — JW Pharmaceutical Share News
0.000.00%
Last trade - 00:00- KR₩620bn
- KR₩609bn
- KR₩775bn
Brief: Jw Pharmaceutical Q2 Operating Profit 25.4 Billion Won, Up 103.3% From Year Earlier
Brief: Jw Pharmaceutical Q1 Operating Profit 22.6 Billion Won, Down 15.4% From Year Earlier
Brief: Jw Pharmaceutical To Acquire 5 Billion Won Worth Of Own Shares
Brief: Jw Pharmaceutical To Acquire 5 Billion Won Worth Of Own Shares
Brief: Jw Pharmaceutical Corp Q3 Operating Profit 26 Billion Won, Down 2% From Year Earlier
Brief: Jw Pharmaceutical Q2 Operating Profit 12.5 Billion Won, Down 45% From Year Earlier
Brief: Jw Pharmaceutical Q1 Operating Profit 27 Billion Won, Up 24% From Year Earlier
Brief: Jw Pharmaceutical Q3 Operating Profit 27 Billion Won, Up 111% From Year Earlier
Brief: Jw Pharmaceutical Q2 Operating Profit 22.7 Billion Won, Up 120.3% From Year Earlier
Brief: Jw Pharmaceutical Corp Q3 Operating Profit 13 Billion Won, Up 48% From Year Earlier
S.Korean drugmakers fall after cancer-causing chemicals found in diabetes products
Brief: Simcere And JW Pharmaceutical Announce Collaboration And License Agreement For Anti-Gout Drug Candidate URC-102 In China
Brief: JW Pharmaceutical Signs $70 Mln Technology Transfer Contract With China's Nanjing Simcere Dongyuan Pharmaceutical
Brief: JW Pharmaceutical to buy back shares worth 10 bln won
Brief: JW Pharmaceutical lowers conversion price of 2nd and 3rd series bonds to 43,954 won/share
Brief: JW Pharmaceutical lowers conversion price of 2th and 3th series convertible bonds to 45,068 won/share
Brief: JW Pharmaceutical to pay annual dividend for FY 2016
Brief: JW PHARMACEUTICAL announces private placement of preferred stock worth 111.9 bln won
Brief: JW PHARMACEUTICAL receives 13.9 bln won fine by Seoul Regional National Tax service